Sept 26, 2020 – Rachael Durie, PharmD at AltaThera presented new data on AFIB dosing to the Alliance of Cardiovascular Professionals. She highlights the clinical benefits of reduced length of hospital stay, especially relevant during COVID. In addition, she explains the hospital cost savings with the 1-day regimen recently approved by FDA.

August 2020 – The publication describes the FDA’s regulatory path for approving new Sotalol IV dosing for a 1-day initiation or dose escalation. The data shows how a 1-hour Sotalol IV infusion can quickly reach therapeutic levels and thus, reduce hospital length of stay from 3 days down to 1 day.

May 2019 – Boston Strategic Group and AltaThera present hospital cost savings by using a 1-day initiation regimen. Over 7,200 patients in the Cerner electronic health record system who were admitted to the hospital for initiation of oral sotalol were analyzed. By reducing 3-day sotalol initiation to a 1-day procedure, the cost-saving per patient is $3,000; a significant reduction in hospital costs.